Age at menarche and its association with dysglycemia in Korean middle-aged women

Menopause

Volumn 22, Issue 5, 2015, Pages 542-548

  Baek, Tae Hwa ^a   Lim, Nam Kyoo ^a   Kim, Min Ju ^a   Lee, Joungwon ^a   Ryu, Seungho ^b   Chang, Yoosoo ^b   Choi, Yuni ^b   Park, Hyun Young ^a  

^a Korea National Institute of Health   (South Korea)

^b School of Medicine   (South Korea)

Author keywords

Diabetes; Dysglycemia; Glycated hemoglobin; Menarche; Prediabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DYSGLYCEMIA; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENARCHE; MIDDLE AGED; OBESITY; PANCREAS ISLET BETA CELL; POSTMENOPAUSE; WAIST CIRCUMFERENCE; ADOLESCENT; AGE; ANALYSIS; BLOOD; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDIABETIC STATE; SOUTH KOREA; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE FACTORS; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MENARCHE; MIDDLE AGED; PREDIABETIC STATE; REPUBLIC OF KOREA; WAIST CIRCUMFERENCE;

EID: 84929050167     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000353     Document Type: Article

References (35)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
2. Spijkerman AM, Dekker JM, Nijpels G, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study. Diabetes Care 2003;26: 2604-2608.
3. Spijkerman AM, Henry RM, Dekker JM, et al. Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study. J Intern Med 2004;256:429-436.
4. Nichols GA, Arondekar B, Herman WH. Complications of dysglycemia and medical costs associated with nondiabetic hyperglycemia. Am J Manag Care 2008;14:791-798.
5. Chen L, Zhang C, Yeung E, et al. Age at menarche and metabolic markers for type 2 diabetes in premenopausal women: the BioCycle Study. J Clin Endocrinol Metab 2011;96:E1007-E1012.
6. Stockl D, Meisinger C, Peters A, et al. Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 Study. PLoS One 2011;6:e26076.
7. Lakshman R, Forouhi NG, Sharp SJ, et al. Early age at menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab 2009;94:4953-4960.
8. Jacobsen BK, Heuch I, Kvåle G. Association of low age at menarche with increased all-cause mortality: a 37-year follow-up of 61, 319 Norwegian women. Am J Epidemiol 2007;166:1431-1437.
9. Lakshman R, Forouhi N, Luben R, et al. Association between age at menarche and risk of diabetes in adults: results from the EPIC-Norfolk cohort study. Diabetologia 2008;51:781-786.
10. He C, Zhang C, Hunter DJ, et al. Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol 2010;171:334-344.
11. Stockl D, Doring A, Peters A, et al. Age at menarche is associated with prediabetes and diabetes in women (aged 32-81 years) from the general population: the KORA F4 Study. Diabetologia 2012;55:681-688.
12. Dreyfus JG, Lutsey PL, Huxley R, et al. Age at menarche and risk of type 2 diabetes among African-American and white women in the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2012;55: 2371-2380.
13. Elks CE, Ong K, Scott RA, et al. Age at menarche and type 2 diabetes risk: the EPIC-InterAct study. Diabetes Care 2013;36:3526-3534.
14. Saquib N, Kritz Silverstein D, Barrett Connor E. Age at menarche, abnormal glucose tolerance and type 2 diabetes mellitus: the Rancho Bernardo Study. Climacteric 2005;8:76-82.
15. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495.
16. American Diabetes Association. Standards of medical care in diabetesV 2010. Diabetes Care 2010;33(suppl 1):S11-S61.
17. Gambineri A, Pelusi C, Manicardi E, et al. Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome: phenotype and associated factors. Diabetes 2004;53:2353-2358.
18. Conway BN, Shu X, Zhang X, et al. Age at menarche, the leg length to sitting height ratio, and risk of diabetes in middle-Aged and elderly Chinese men and women. PLoS One 2012;7:e30625.
19. Mueller NT, Odegaard AO, Gross MD, Koh WP, Yuan JM, Pereira MA. Age at menarche and cardiovascular disease mortality in Singaporean Chinese women: the Singapore Chinese Health Study. Ann Epidemiol 2012;22:717-722.
20. Qiu C, Chen H, Wen J, et al. Associations between age at menarche and menopause with cardiovascular disease, diabetes, and osteoporosis in Chinese women. J Clin Endocrinol Metab 2013;98:1612-1621.
21. Feng Y, Hong X, Wilker E, et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008;196:590-597.
22. Anderson SE, Must A. Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. J Pediatr 2005;147:753-760.
23. FredriksAM, van Buuren S, Burgmeijer RJ, et al. Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 2000;47:316-323.
24. Graham MJ, Larsen U, Xu X. Secular trend in age at menarche in China: a case study of two rural counties in Anhui Province. J Biosoc Sci 1999;31: 257-267.
25. Cho GJ, Park HT, Shin JH, et al. Age at menarche in a Korean population: secular trends and influencing factors. Eur J Pediatr 2010;169:89-94.
26. Cho NH. The epidemiology of diabetes in Korea: from the economics to genetics. Korean Diabetes J 2010;34:10-15.
27. van Lenthe FJ, Kemper CG, van Mechelen W. Rapid maturation in adolescence results in greater obesity in adulthood: the Amsterdam Growth and Health Study. Am J Clin Nutr 1996;64:18-24.
28. Okasha M, McCarron P, McEwen J, Smith GD. Age at menarche: secular trends and association with adult anthropometric measures. Ann Hum Biol 2001;28:68-78.
29. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-846.
30. Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987; 64:51-58.
31. RoomanRP, De Beeck LO, MartinM, vanDoorn J, Mohan S, Du CajuMV. Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature. Eur J Endocrinol/Eur Fed Endocr Soc 2005;152:597-604.
32. Teppala S, Shankar A. Association between serum IGF-1 and diabetes among U.S. adults. Diabetes Care 2010;33:2257-2259.
33. Casey VA, Dwyer JT, Coleman KA, Krall EA, Gardner J, Valadian I. Accuracy of recall by middle-Aged participants in a longitudinal study of their body size and indices of maturation earlier in life. Ann Hum Biol 1991;18:155-166.
34. Must A, Phillips SM, Naumova EN, et al. Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember?. Am J Epidemiol 2002;155:672-679.
35. Picardi A, Cipponeri E, Bizzarri C, Fallucca S, Guglielmi C, Pozzilli P. Menarche in type 1 diabetes is still delayed despite good metabolic control. Fertil Steril 2008;90:1875-1877.